Novel Drug Shows Promise in T-Cell Lymphoma

DENVER (MedPage Today) -- An investigational drug, resiquimod, successfully healed cutaneous T-cell lymphoma lesions in a small peer-supported trial, researchers reported here.
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news